Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society

Eur Respir J. 1999 May;13(5):1198-208. doi: 10.1034/j.1399-3003.1999.13e43.x.

Authors

Affiliation

¹ National Heart & Lung Institute, Imperial College School of Medicine, London, UK.

PMID: 10414427
DOI: 10.1034/j.1399-3003.1999.13e43.x

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Adult
Allergens
Anti-Asthmatic Agents
Asthma / diagnosis
Asthma / prevention & control
Asthma / therapy*
Bronchodilator Agents
Child
Environmental Exposure
Humans

Substances

Allergens
Anti-Asthmatic Agents
Bronchodilator Agents